Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

AIMS/HYPOTHESIS: Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, c...

Detaylı Bibliyografya
Asıl Yazarlar:	Turnbull, F, Abraira, C, Anderson, R, Byington, R, Chalmers, J, Duckworth, W, Evans, G, Gerstein, H, Holman, R, Moritz, T, Neal, B, Ninomiya, T, Patel, A, Paul, S, Travert, F, Woodward, M
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
Yazar:: Karunakaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
Yazar:: Woodward, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
Yazar:: Hata, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
Yazar:: Hata, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
Yazar:: Hata, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
Yazar:: Mohammedi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

FPG and HbA(1c) are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
Yazar:: Kim, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Envolvimento macrovascular e esclerose sistêmica Macrovascular involvement and systemic sclerosis
Yazar:: Emmanuelle Tenório Albuquerque Madruga Godoi, ve diğerleri
Baskı/Yayın Bilgisi: (2009-03-01)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
Yazar:: Stettler, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
Yazar:: Lv, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
Yazar:: Velia Cassano, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
Yazar:: Érika B. Rangel, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
Yazar:: Shoujiang You, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Type 2 Diabetes Mellitus and Macrovascular Complications
Yazar:: Peng-Fei Shan, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
Yazar:: Turnbull, F, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
Yazar:: Welsh, P, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Exploring Mechanisms of Diabetes-Related Macrovascular Complications: Role of Methylglyoxal, a Metabolite of Glucose on Regulation of Vascular Contractility
Yazar:: Masashi Mukohda, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Prevalence of micro and macrovascular complications of diabetes detected at single visit screening
Yazar:: B M A C Balasuriya, ve diğerleri
Baskı/Yayın Bilgisi: (2012-05-01)

Molecular Mechanisms of Methylglyoxal in Diabetes-related Macrovascular Complications
Yazar:: Anna Meiliana, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Yazar:: Aastha Chawla, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Macrovascular complication phenotypes in type 2 diabetic patients
Yazar:: Papa Giuseppe, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

10-year follow-up of intensive glucose control in type 2 diabetes.
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
Yazar:: Jicheng Lv, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Yazar:: Perkovic, V, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
Yazar:: Bijan Roshan, ve diğerleri
Baskı/Yayın Bilgisi: (2010-12-01)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
Yazar:: Jung Hee Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
Yazar:: L. Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
Yazar:: Bao Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Yazar:: Anubhav Chauhan, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

HIV‐Associated Cardiovascular Disease: Beyond the Macrovascular
Yazar:: Ashley B. Pournamdari, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Symposium 13: Impact of prediabetes on macrovascular disease
Yazar:: Carolina Gómez Martin
Baskı/Yayın Bilgisi: (2022-09-01)